Follow The Filings

SOLV Solventum Corporation

Health Care, filed as SOLVENTUM CORP (COM SHS), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Sold by 1 manager in 2026 Q2

  • 2 Owners
  • #249
  • Max 0.1%
  • Master 0.07%
  • $36M
  • 1 reduce

In 2026 Q3 Richard Pzena trimmed Solventum.

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Richard Pzena, Pzena Investment Management). Not free-float ownership.

  1. Richard Pzena Reduce 0.11%
  2. Kentucky Trust Co. 0.01%

Who owns SOLV

Sorted by value, long equity only, as of 2026 Q3.

History
Richard Pzena, Pzena Investment Management 0.11% Reduce −2.5% 407,249 $36M History
Kentucky Trust Co., Kentucky Trust 0.01% Hold 156 $14K History

2 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by SOLV's executives, directors and 10% owners in the last 12 months, from their Form 4s

All SOLV insider trades
  • $100K bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Amy McBride Wendell Director
    Buy
    $100K 1,475 shares at $68.03 +41% to stake
    Traded Mar 10 Filed Mar 11
    ↗

Also filed in the last 12 months, not counted as buying or selling: 42 option exercises and 20 share withholdings for taxes.

Congress

6 members of Congress traded SOLV in the last three years: 1 buy and 5 sales. 4 members listed it in 2025 annual reports.

All Congress trades
  1. Alan Armstrong R-OK Buy $1K–$15K Mar 27 filed Jul 21
  2. J. French Hill R-AR-2 Sell $15K–$50K Dec 31, 2025 filed Jan 23
  3. Ron Wyden D-ORSpouse Sell $1K–$15K Feb 6, 2025 filed Feb 21, 2025
  4. Julie Johnson D-TX-32Joint Sell $1K–$15K Jan 15, 2025 filed Feb 12, 2025
  5. Tommy Tuberville R-ALJoint Sell $1K–$15K May 3, 2024 filed Jun 14, 2024
  6. Gary C. Peters D-MI Sell $1K–$15K May 14, 2024 filed May 23, 2024

SEC filings

Recent issuer filings from EDGAR, 9 shown.

Filed Form Detail Links
8-K 7.01,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc

Source: SEC EDGAR submissions, updated about 2 months ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2024 FY2025
Revenue $8.25B $8.32B
Gross profit $4.59B $4.45B
Gross margin * 55.6% 53.5%
Net income $0.479B $1.56B
Net margin * 5.8% 18.7%

Balance sheet

Metric FY2024 FY2025
Total current assets $3.25B $3.86B
Total non-current assets * $11.21B $10.44B
Total assets $14.46B $14.29B
Total current liabilities $2.7B $3.14B
Total non-current liabilities * $8.8B $6.11B
Total equity $2.96B $5.05B

Cash flow

Metric FY2024 FY2025
Cash from operations $1.18B $0.369B
Cash from investing -$0.38B $2.8B
Cash from financing -$0.24B -$3.06B
Net change in cash $568M $116M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.